Skip to main content
Log in

Nucleolar characteristics of reducing bodies in reducing body myopathy

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Reducing body myopathy is a rare muscle disease defined by abnormal inclusions in affected muscle fibers that can be stained with menadione-nitroblue tetrazolium. The origin of these inclusions has not been determined. Here we show that reducing bodies bear characteristics of nucleoli. Ultrastructurally, muscle biopsy specimens of a patient with adult-onset reducing body myopathy showed granular structures of reducing bodies with features similar to the granules of nucleoli, which consisted of pre-ribosomes. In addition, reducing bodies were positive for histochemistry of argyrophilic nucleolar organizer regions (a method for detecting the areas where ribosomal RNA is actively transcribed in the nucleolus), and for antibodies against nucleoli and nuclear ribonucleoprotein. The current findings suggest that reducing bodies contain pre-ribosomes and their associated proteins of the nucleolus and that formation of reducing bodies may result from defects of processing and assembly of ribosomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Brooke MH, Neville HE (1972) Reducing body myopathy. Neurology 22:829–840

    CAS  PubMed  Google Scholar 

  2. Carpenter S, Karpati G, Holland P (1985) New observations in reducing body myopathy. Neurology 35:818–827

    CAS  PubMed  Google Scholar 

  3. Clevenger CV, Epstein AL (1984) Use of immunogold electron microscopy and monoclonal antibodies in the identification of nuclear substructures. J Histochem Cytochem 32:757–765

    CAS  PubMed  Google Scholar 

  4. Derenzini M, Ploton D (1991) Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 32:149–192

    CAS  PubMed  Google Scholar 

  5. Epstein AL, Clevenger CV (1985) Identification of nuclear antigens in human cells by immnuofluorescence, immnuoelectron microscopy, and immunobiochemical methods using monoclonal antibodies. In: Bekhor I (ed) Progress in nonhistone protein research, vol 1, CRC Press, Boca Raton, pp 117–137

  6. Goebel HH, Halbig LE, Goldfarb L, Schober R, Albani M, Neuen-Jacob E, Voit T (2001) Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: a mixed congenital myopathy. Neuropediatrics 32:196–205

    Article  CAS  PubMed  Google Scholar 

  7. Kiyomoto BH, Murakami N, Kobayashi Y, Nihei K, Tanaka T, Takeshita K, Nonaka I (1995) Fatal reducing body myopathy. Ultrastructural and immunohistochemical observations. J Neurol Sci 128:58–65

    Article  CAS  PubMed  Google Scholar 

  8. Lindner LE (1993) Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). J Histochem Cytochem 41:439–445

    CAS  PubMed  Google Scholar 

  9. Oh SJ, Meyers GJ, Wilson ER Jr, Alexander CB (1983) A benign form of reducing body myopathy. Muscle Nerve 6:278–282

    CAS  Google Scholar 

  10. Olsen MOJ, Dundr M, Szebeni A (2000) The nucleolus: an old factory with unexpected capabilities. Trends Cell Biol 10:189–196

    CAS  PubMed  Google Scholar 

  11. Reichmann H, Goebel HH, Schneider C, Toyka KV (1996) Familial mixed congenital myopathy with rigid spine phenotype. Muscle Nerve 20:411–417

    Article  Google Scholar 

  12. Roussel P, Hernandez-Verdun D (1994) Identification of Ag-NOR proteins, markers of proliferation related to ribosomal gene activity. J Histochem Cytochem 42:1513–1517

    CAS  PubMed  Google Scholar 

  13. Scheer U, Hock R (1999) Structure and function of the nucleolus. Curr Opin Cell Biol 11:385–390

    CAS  PubMed  Google Scholar 

  14. Shaw PJ (1995) The nucleolus. Annu Rev Cell Dev Biol 11:93–121

    CAS  PubMed  Google Scholar 

  15. Tomé FM, Fardeau M (1975) Congenital myopathy with “reducing bodies” in muscle fibres. Acta Neuropathol (Berl) 31:207–217

    Google Scholar 

  16. Tschochner H, Hurt E (2003) Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends Cell Biol 13:255–263

    Article  CAS  PubMed  Google Scholar 

  17. Tuccari G, Giuffre G, Crisafulli C, Monici MC, Toscano A, Vita G (1999) Quantitation of argyrophilic nucleolar organizer regions in regenerating muscle fibers in Duchenne and Becker muscular dystrophies and polymyositis. Acta Neuropathol 97:247–252

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS (C-13670676) and a Grant from Kansai Medical University (Research Grant B). We thank Ms. Hitomi Nakabayashi for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi Nakano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shinde, A., Nakano, S., Kusaka, H. et al. Nucleolar characteristics of reducing bodies in reducing body myopathy. Acta Neuropathol 107, 265–271 (2004). https://doi.org/10.1007/s00401-003-0806-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-003-0806-y

Keywords

Navigation